Remove 2028 Remove Patients Remove Prescription
article thumbnail

US companies drive 2023 drug launches positioned for blockbuster success by 2028

Pharmaceutical Technology

According to GlobalData’s Looking Ahead to 2023 – the Future of Pharma report, five drugs set for approval in 2023 are projected to attain blockbuster status or near-blockbuster status by 2028 with US company dominance. These drugs are set to make a combined $4.34bn in sales in 2028. Similarly, Almirall S.A.,

Sales 105
article thumbnail

Pharma’s reputational high will be short-lived

World of DTC Marketing

Another biologic, Enbrel, on the market since 1998, will not have its $5 billion in sales challenged until the end of 2028. Billions in excess drug costs are shouldered by employers, taxpayers and patients as a result. I’m not sure why so many people make the jump from wanting to help patients to “what’s the ROI?

Pharma 186
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Ipsen beefs up in oncology, buying US biopharma Epizyme

pharmaphorum

The bolt-on deal comes shortly after Ipsen announced plans to sell its consumer health business for around €350 million, leaving it as a pure-play prescription pharma operating in the cancer, rare diseases and neuroscience categories. Ipsen is offering $1.45 Ipsen’s CVR offer includes $0.30

Biopharma 110
article thumbnail

Elite Teledentistry Companies in the USA

Medico Reach

Teledentistry has made dental services easily accessible to patients. million by 2028 , with more teledentistry companies entering the market. LiveDentist connects patients with certified dental experts to receive immediate treatment, consultation, and suggestions. Customers can avail dental services right from their comfort.

article thumbnail

Consequences of the First 10 Drugs Selected for Medicare’s Negotiation Program

PM360

As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry. However, the impact of the new law will reverberate in the industry for years to come.

article thumbnail

Your Guide to Virtual Reality Reimbursement in the U.S. Healthcare Market

Nixon Gwilt Law

Providers are already integrating Virtual Reality ( VR ) into patient care in a variety of ways. So, how do patients get access to this technology, and how do providers get paid for using it? Reimbursement impacts patient access, business and revenue models, investment potential, and product development.

article thumbnail

Compliance to convenience: understanding the latest innovations in capsule formulation

Pharmaceutical Technology

When it comes to pharmaceutical, nutritional or cosmeceutical dosing, some of the most crucial parameters are safety, product effectiveness and patient adherence. Softgel capsules, containing a liquid, paste or emulsion active ingredient, are trusted and favoured by many patients. billion by 2028, at a CAGR of 12.6%.